Reproductive role of prolactin

Reproduction

Volumn 133, Issue 2, 2007, Pages 361-369

  Bachelot, Anne ^a,b,c   Binart, Nadine ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; BUTYROPHENONE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; DOMPERIDONE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; FLUOXETINE; GONADORELIN; GROWTH HORMONE; HALOPERIDOL; JANUS KINASE 2; METHYLDOPA; METOCLOPRAMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OPIATE; PHENOTHIAZINE DERIVATIVE; PROLACTIN; PROLACTIN RECEPTOR; PSYCHOTROPIC AGENT; RESERPINE; SEROTONIN UPTAKE INHIBITOR; STAT5 PROTEIN; SULPIRIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL;

BREAST DEVELOPMENT; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CORPUS LUTEUM; GENE EXPRESSION; GONADORELIN RELEASE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; MALE FERTILITY; MATERNAL BEHAVIOR; MOLECULAR CLONING; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROLACTINOMA; PUERPERIUM; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CORPUS LUTEUM MAINTENANCE; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; PREGNANCY; PROGESTERONE; PROLACTIN; RECEPTORS, PROLACTIN; REPRODUCTION; SIGNAL TRANSDUCTION;

MUS;

EID: 33847671032     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/REP-06-0299     Document Type: Review

References (67)

1. Ahonen TJ, Harkonen PL, Laine J, Rui H, Martilkainen PM & Nevalainen MT 1999 Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture. Endocrinology 140 5412-5421.
2. Ali S, Chen Z, Lebrun JJ, Vogel W, Kharitonenkov A, Kelly PA & Ullrich A 1996 PTP1D is a positive regulator of the prolactin signal leading to β-casein promoter activation. EMBO Journal 15 135-142.
3. Baldocchi RA, Tan L, King DS & Nicoll CS 1993 Mass spectrometric analysis of the fragments produced by cleavage and reduction of rat prolactin: evidence that the cleaving enzyme is cathepsin D. Endocrinology 133 935-938.
4. Ben-Jonathan N, Mershon JL, Allen DL & Steinmetz RW 1996 Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocrine Review 17 639-669.
5. Berlanga JJ, Gualillo O, Buteau H, Applanat M, Kelly PA & Edery M 1997 Prolactin activates tyrosyl phosphorylation of insulin receptor substrate-1 and phosphatidylinositol-3-OH kinase. Journal of Biological Chemistry 272 2050-2052.
6. Bernichtein S, Kinet S, Jeay S, Madern M, Martial IA, Kelly PA & Goffin V 2001 S179D-hPRL, a pseudo-phosphorylated human prolactin analog, is an agonist and not an antagonist. Endocrinology 142 3950-3963.
7. Binart N, Helloco C, Ormandly CJ, Barra J, Clement-Lacroix P, Baran N & Kelly PA 2000 Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration. Endocrinology 141 2691-2697.
8. Binart N, Imbert-Bollore P, Baran N, Viglietta C & Kelly PA 2003a A short form of the prolactin receptor is able to rescue mammopoiesis in heterozygous prolactin receptor mice. Molecular Endocrinology 17 1066-1074.
9. Binart N, Melaine N, Pineau C, Kercret H, Touzalin AM, Imbert-Bollore P, Kelly PA & legou B 2003b Male reproductive function is not affected in prolactin receptor-deficient mice. Endocrinology 144 3779-3782.
10. Bole-Feysot C, Goffin V, Edery M, Binart N & Kelly PA 1998 Prolactin and its receptor: actions, signal transduction pathways and phenotypes observed in prolactin receptor knockout mice. Endocrine Review 19 225-268.
11. Bouchard P, Lagoguey M, Brailly S & Schaison G 1985 Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism 60 258-262.
12. Bridges RS, Rigero BA, Byrnes EM, Yang L & Walker AM 2001 Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid- primed, nulliparous female rats. Endocrinology 142 730-739.
13. Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, Kelly PA & Ormandly CJ 1999 Prolactin controls mammary gland development via direct and indirect mechanisms. Developmental Biology 210 96-106.
14. Brisken C, Ayyannan A, Nguyen C, Heineman A, Reinhardt F, Tan J, Dey SK, Dotto GP, Weinberg RA & Jan T 2002 IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Developmental Cell 3 877-887.
15. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW et al. 2005 Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nature Structural and Molecular Biology 12 814-821.
16. Camarillo IG, Thordarson G, Moffat JG, Van Horn KM, Binart N, Kelly PA & Talamantes F 2001 Prolactin receptor expression in the epithelia and stroma of the rat mammary gland. Journal of Endocrinology 171 85-95.
17. Clevenger CV, Ngo W, Sokol DL, Luger SM & Gewirtz AM 1995 Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. Journal of Biological Chemistry 270 13246-13253.
18. Colao A, Vitale G, Di Sarno A, Spiezia S, Guerra E, Ciccarelli A & Lombardi G 2004 Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma. Journal of Clinical Endocrinology and Metabolism 89 2770-2775.
19. Crosignani PG 1999 Management of hyperprolactinemia in infertility. Journal of Reproductive Medicine 44 1116-1120.
20. Davis JS, Rueda BR & Spanel-Borowski K 2003 Microvascular endothelial cells of the corpus luteum. Reproductive Biology and Endocrinology 1 89.
21. Elbourne KB, Keisler D & McMurray RW 1998 Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus. Lupus 7 420-427.
22. Feltus FA, Groner B & Melner MH 1999 Stat5-mediated regulation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene: activation by prolactin. Molecular Endocrinology 13 1084-1093.
23. Frasor J & Gibori G 2003 Prolactin regulation of estrogen receptor expression. Trends in Endocrinology and Metabolism 14 118-123.
24. Freeman ME, Kanyicska B, Lerant A & Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiological Reviews 80 1523-1631.
25. Gadd SL & Clevenger CV 2006 Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Molecular Endocrinology 11 2734-2746.
26. Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano K, Perry J, Kopchick J, Oka T, Kelly PA & Hermighausen L 2001 Prolactin, growth hormone and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Developmental Biology 229 163-175.
27. Grosdemouge I, Bachelot A, Lucas A, Baran N, Kelly PA & Binart N 2003 Effects of deletion of the prolactin receptor on ovarian gene expression. Reproductive Biology and Endocrinology 1 1-12.
28. Gu Y, Srivastava RK, Clarke DL, Linzer Di & Gibori G 1996 The decidual prolactin receptor and its regulation by decidua-derived factors. Endocrinology 137 4878-4885.
29. Horseman ND & Yu-Lee LY 1994 Transcriptional regulation by the helix bundle pepticle hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocrine Review 15 627-649.
30. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F. Markoff E & Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO Journal 16 6926-6935.
31. Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, Sundararajan K & Vonderhaar BK 2001 Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Developmental Dynamics 222 192-205.
32. Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandly CJ & Vonderhaar BK 2003 Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Molecular Endocrinology 17 460-471.
33. Ihle JN 1996 STATs: signal transducers and activators of transcription. Cell 84 331-334.
34. Ihle JN & Kerr IM 1995 Jaks and Stats in signaling by the cytokine receptor superfamily. Trends in Genetics 11 69-74.
35. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A & Hennighausen I. 1997 Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes and Development 11 179-186.
36. Lucas BK, Ormandy C, Binart N, Bridges RS & Kelly PA 1998 Null mutation of prolactin receptor gene produces a defect in maternal behavior. Endocrinology 139 4102-4107.
37. Marshall JC, Eagleson CA & McCartney CR 2001 Hypothalamic dysfunction. Molecular and Cellular Endocrinology 183 29-32.
38. Miyoshi K, Shillingford JM, Smith GH, Grimm SL, Wagner KILI, Oka T, Rosen JM, Robinson GW & Hermighausen L 2001 Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. Journal of Cell Biology 155 531-542.
39. Molitch ME 2003 Pituitary tumors and pregnancy. Growth Hormone and IGF Research 13 S38-S44. Suppl A.
40. Nandi S 1958 Endocrine control of mammary gland development and function in the C3H/He Crgl mouse. Journal of the National Cancer Institute 21 1039-1063.
41. Nevalainen MT, Valve EM, Ahonen T, Yagi A, Paranko J & Harkonen PL 1997a Androgen-dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture. FASEB Journal 11 1297-1307.
42. Nevalainen MT, Valve EM, Ingleton PM, Nurmi M, Martikainen PM & Harkonen PL 1997b Prolactin and prolactin receptors are expressed and functioning in human prostate. Journal of Clinical Investigation 99 618-627.
43. Neville MC & Daniel CW 1987 The Mammary Gland: Development Regulation and Function, New York: Plenum Press.
44. Nilsson J, Bjursell G & Kannius-Janson M 2006 Nuclear Jak2 and transcription factor NFI-C2: a novel mechanism of prolactin signaling in mammary epithelial cells. Molecular and Cellular Biology 26 5663-5674.
45. Niswender GD, Juengel JL, Silva PJ, Rollyson MK & McIntush EW 2000 Mechanisms controlling the function and life span of the corpus luteum. Physiological Reviews 80 1-29.
46. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas BK, Buteau H, Edery M, Brousse N, Babinet C, Binart N et al. 1997 Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes and Development 11 167-178.
47. Ormandy CJ, Naylor M, Harris J, Robertson F, Horseman ND, Lindeman GJ, Visvader J & Kelly PA 2003 Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Progress in Hormone Research 58 297-323.
48. Piwnica D, Fernandez I, Binart N, Touraine P, Kelly PA & Goffin V 2006 A new mechanism for prolactin (PRL) processing into 16K PRL by secreted cathepsin D. Molecular Endocrinology 20 3263-3278.
49. Prigent-Tessier A, Tessier C, Hirosawa-Takamori M, Boyer C, Ferguson-Gottschall S & Gibori G 1999 Rat clecidual prolactin. Identification, molecular cloning, and characterization. Journal of Biological Chemistry 274 3 7982-37989.
50. Qazi AM, Tsai-Morris CH & Dufau ML 2006 Ligand-independent homo- and hetero-dimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. Molecular Endocrinology 8 1912-1923.
51. Reynolds LP & Redmer DA 1999 Growth and development of the corpus luteum. Journal of Reproduction and Fertility Supplement 54 181-191.
52. Risk M & Gibori G 2001 Mechanisms of luteal cell regulation by prolactin. In Prolactin, pp 265-295. Ed. ND Horseman. Boston: Kluwer Academic Publishers.
53. Robertson FG, Harris J, Naylor MJ, Oakes SR, Kindblom J, Dillner K, Wennbo H, Tornell J, Kelly PA, Green J et al. 2003 Prostate development and carcinogenesis in prolactin receptor knockout mice. Endocrinology 144 3196-3205.
54. Saunier E, Dif F, Kelly PA & Edery M 2003 Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation. Endocrinology 144 2669-2675.
55. Shingo T, Gregg C, Enwere E, Fujikawa H. Hassam R, Geary C, Cross JC & Weiss S 2003 Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin. Science 299 117-120.
56. Sinha YN 1995 Structural variants of prolactin: occurence and physiological significance. Endocrine Review 16 354-369.
57. Sobrinho LG 2003 Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary 6 35-39.
58. Steger RW, Chandrashekar V, Zhao W, Bartke A & Horseman ND 1998 Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139 3691-3695.
59. Tamanini C & De Ambrogi M 2004 Angiogenesis in developing follicle and corpus luteum. Reproduction in Domestic Animals 39 206-216.
60. Tan D, Johnson DA, Wu W, Zeng L, Chen YH, Chen WY, Vonderhaar BK & Walker AM 2005 Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells. Molecular Endocrinology 19 1291-1303.
61. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ & Davey HW 1997 Requirement of Stat5b for sexual dimorphism of body growth rates and liver gene expression. PNAS 94 7239-7244.
62. Wakao H, Gouilleux F & Groner B 1995 Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO Journal 14 854-855.
63. Walker SE, Miller D, Hill DL & Komatireddy GR 1998 Prolactin, a pituitary hormone that modifies immune responses. Proceedings of the Mini-symposium on Prolactin and SLE, held at the 5th International Conference on Systemic Lupus Erythematosus, Cancun, Mexico. Lupus 7 371-375.
64. Webb R, Woad KJ & Armstrong DG 2002 Corpus luteum (CL) function: local control mechanisms. Domestic Animal Endocrinology 23 277-285.
65. Wu W, Coss D, Lorenson MY, Kuo CB, Xu X & Walker AM 2003 Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways. Biochemistry 42 7561-7570.
66. Yu-Lee LY 1997 Molecular actions of actions of prolactin in the immune system. Proceedings of the Society for Experimental Biology Medicine 215 35-51.
67. Zinaman MJ, Cartledge T, Tomai T, Tippett P & Merriam GR 1995 Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women. Journal of Clinical Endocrinology and Metabolism 80 2088-2093.